Oncternal Therapeutics Inc ONCT Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Oncternal Therapeutics Inc (ONCT)
Oncternal Therapeutics Inc (ONCT) Financials

Oncternal Therapeutics Inc (ONCT)

0.00

0.00

(0.00%)

Closed June 29 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-62.703	-86.061	-99.07	-128.853	-24.51	-29.505	-54.452	-74.927
Return on Equity (%)	-162.979	-104.688	-119.362	-169.151	-27.07	-31.166	-59.253	-86.747
Return on Invested Capital (%)	-238.464	-105.431	-121.354	-166.976	-27.904	-31.421	-61.087	-93.388
Operating Margin (%)	N/A	N/A	N/A	-1409.814	-510.37	-726.141	-2964.43	-5029.172
Net Profit Margin (%)	N/A	N/A	N/A	-1409.814	-510.37	-726.141	-2964.43	-5029.172
Book Value Per Share	1.242	1.771	1.082	0.93	2.314	1.783	1.061	0.51
Earnings Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
Cash Per Share	0.56	0.734	1.175	1.303	2.392	1.836	0.646	0.114
Working Capital Per Share	1.237	1.769	1.081	0.874	2.298	1.768	1.037	0.523
Operating Profit Per Share	N/A	N/A	N/A	0.158	0.069	0.087	0.026	0.013
EBIT Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
EBITDA Per Share	-1.113	-1.413	-1.597	-2.222	-0.353	-0.634	-0.769	-0.669
Free Cash Flow Per Share	-1.109	-1.414	-1.599	-2.222	-0.353	-0.634	-0.769	-0.669

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	5.27	5.778	5.99	2.832	20.144	16.99	8.759	6.937
Quick Ratio	4.743	5.505	5.462	2.731	19.928	16.608	8.295	6.59
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	15.92M	21.54M	24.05M	15.39M	48.8M	49.43M	57.46M	N/A

Key Stats and Ratios

Year End December 30 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	49.43M	52.15M	55.52M	57.46M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-1327.614	N/A	N/A	N/A	-5658.621	N/A	N/A	N/A
Net Profit Margin (%)	-1327.614	N/A	N/A	N/A	-5658.621	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	16.068	N/A	N/A	N/A	10.553	N/A	N/A	N/A
Quick Ratio	15.519	N/A	N/A	N/A	9.897	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	22.52M
Price to Earnings Ratio	-0.57
Price to Sales Ratio	28.7
Price to Cash Ratio	3.36
Price to Book Ratio	0.75
Dividend Yield	-

Share Statistics

Shares Outstanding	2.96M
Average Volume (1 week)	7.19k
Average Volume (1 Month)	6.1k
52 Week Change	0.00%
52 Week High	13.14
52 Week Low	5.5656

More Ratios Coming Soon!

Oncternal Therapeutics

Vontobel Financial Produ...

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions